Research location
Hachiōji
Japan
Advertisement
Research activity in Hachiōji
JapanCureCurrent currently publishes aggregate city-level research activity for this location: 18 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hachiōji
18 linked trials · page 1 of 1A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventNCT07783802 · 2026-08-27 · 1 site observation
RECRUITING
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).NCT07602582 · 2026-05-22 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 1 site observation
RECRUITING
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseaseNCT06809400 · 2025-02-18 · 1 site observation
RECRUITING
A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese ParticipantsNCT06869018 · 2025-05-07 · 1 site observation
COMPLETED
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)NCT06653153 · 2024-10-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of LY3971297 in Healthy ParticipantsNCT06148272 · 2023-12-07 · 1 site observation
COMPLETED
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)NCT05026866 · 2021-08-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseNCT04619420 · 2021-01-06 · 1 site observation
TERMINATED
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease DementiaNCT02791191 · 2016-06-16 · 1 site observation
TERMINATED
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseNCT02760602 · 2016-06-01 · 1 site observation
TERMINATED
A Study of Paliperidone Palmitate in Japanese Patients With SchizophreniaNCT01258920 · 2010-10-01 · 1 site observation
COMPLETED
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01202188 · 2010-09-01 · 1 site observation
COMPLETED
Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term UseNCT01050062 · 2010-01-01 · 2 site observations
COMPLETED
A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)NCT00771251 · 2008-05-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyNCT00727987 · 2008-05-01 · 1 site observation
COMPLETED
Survey on PD Patients With Depressive SymptomsNCT00614575 · 2007-01-01 · 1 site observation
COMPLETED
Special Survey on PD Patients With Renal DysfunctionNCT00613756 · 2004-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.